CLMT Stock Jumps As Revenue Beat Fuels Deleveraging Story
Aug 10, 2026
Calumet Specialty Products Partners stock surged over 10% following a Q2 revenue beat of $1.45 billion, aided by debt reduction and the Montana Renewables MaxSAF project. Goldman Sachs raised its price target to $40 amidst cautious optimism.
Show all 11 updates